Wells Fargo
CYTK icon

Wells Fargo’s Cytokinetics CYTK Stock Holding History

Wells Fargo’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-100
Closed -$5.5K – 7163
2025
Q3 		$5.5K Buy
+100
New +$4.12K ﹤0.01% 6060

Other funds holding CYTK

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wells Fargo's CYTK Position: Q1 2026 in Review

Wells Fargo reduced its Cytokinetics (CYTK) stake by 54% in Q1 2026, selling an estimated $5.54M and leaving 74,342 shares worth $4.9M. The position accounts for ﹤0.01% of the portfolio, ranked #2614.

Wells Fargo first reported a position in CYTK in Q3 2013 and has held it in 51 quarters since. The position peaked at $10.3M in Q4 2025. 439 funds tracked by Wall St. Rank hold CYTK as of Q1 2026.

  • Wells Fargo held 74,342 shares of Cytokinetics worth $4.9M as of Q1 2026.
  • Wells Fargo sold 87,214 Cytokinetics shares in Q1 2026, an estimated $5.54M.
  • Cytokinetics made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #2614 holding.
  • Wells Fargo first reported a position in Cytokinetics in Q3 2013 and has held it in 51 quarters since.
  • Wells Fargo's Cytokinetics position peaked at $10.3M in Q4 2025.
  • 439 funds tracked by Wall St. Rank held Cytokinetics as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.